Comparison of the effects of repetitive low-dose and single-dose antigen challenge on airway inflammation

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 4, 2003, Pages 818-825

  Liu, Lin Ying ^a   Swenson, Cheri A ^a   Kelly, Elizabeth A ^a   Kita, Hirohito ^b   Jarjour, Nizar N ^a   Busse, William W ^a,c  

^a University of Wisconsin Health   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Allergen; Eosinophils; Low dose provocation; Sputum induction

Indexed keywords

ALLERGEN; ANTIGEN; FIBRONECTIN; NEUROTOXIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; EOSINOPHILIA; EXPOSURE; FEMALE; HUMAN; LOW DRUG DOSE; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; SPUTUM;

EID: 0037391792     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1346     Document Type: Article

References (32)

1. Gauvreau GM, Watson RM, O'Byrne PM. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. Am J Respir Crit Care Med 1999;160:640-7.
2. Jarjour NN, Calhoun WJ, Kelly EA, Gleich GJ, Schwartz LB, Busse WW. The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. Am J Respir Crit Care Med 1997;155:1515-21.
3. Pizzichini E, Pizzichini MM, Kidney JC, Efthimiadis A, Hussack P, Popov T, et al. Induced sputum, bronchoalveolar lavage and blood from mild asthmatics-inflammatory cells, lymphocyte subsets and soluble markers compared. Eur Respir J 1998;11:828-34.
4. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-17.
5. Pin I, Freitag AP, O'Byrne PM, Girgis-Gabardo A, Watson RM, Dolovich J, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992;145:1265-9.
6. de Bruin-Weller MS, Weller FR, de Monchy JG. Repeated allergen challenge as a new research model for studying allergic reactions. Clin Exp Allergy 1999;29:159-65.
7. Sterk PJ. Repeated low dose allergen exposure: a new investigational model of asthma as a persistent disease? Eur Respir J 1998;11:798-800.
8. Rasmussen JB. Late airway response increases at repeat allergen challenge. Allergy 1991;46:419-26.
9. Sulakvelidze I, Inman MD, Rerecich T, O'Byrne PM. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics. Eur Respir J 1998;11:821-7.
10. Palmqvist M, Pettersson K, Sjostrand M, Andersson B, Lowhagen O, Lotvall J. Mild experimental exacerbation of asthma induced by individualised low-dose repeated allergen exposure. A double-blind evaluation. Respir Med 1998;92:1223-30.
11. Roquet A, Lagging E, Ihre E, Hage-Hamsten M, Hallden G, Harfast B, et al. No signs of activity markers in peripheral blood despite increased bronchial reactivity after repeated low-dose allergen exposure. APMIS 1998;106:293-9.
12. Ihre E, Zetterstrom O. Increase in non-specific bronchial responsiveness after repeated inhalation of low doses of allergen. Clin Exp Allergy 1993;23:298-305.
13. Arshad SH, Hamilton RG, Adkinson NF Jr. Repeated aerosol exposure to small doses of allergen. A model for chronic allergic asthma. Am J Respir Crit Care Med 1998;157:1900-6.
14. Lensmar C, Prieto J, Dahlen B, Eklund A. Grunewald J, Roquet A. Airway inflammation and altered alveolar macrophage phenotype pattern after repeated low-dose allergen exposure of atopic asthmatic subjects. Clin Exp Allergy 1999;29:1632-40.
15. de Blay F, Krieger P, Spirlet F, Moreau L, Duvernelle C, Kassel O, et al. Repeated inhalation of low doses of cat allergen that do not induce clinical symptoms increases bronchial hyperresponsiveness and eosinophil cationic protein levels. Int Arch Allergy Immunol 1999;120:158-65.
16. Liu LY, Swenson CA, Kita H, Kelly EAB, Busse WW. The relationship of airway eosinophilia and sputum cell generation of IL-5 following antigen challenge. J Allergy Clin Immunol 2000;106:1063-9.
17. Kelly EA, Rodriguez RR, Busse WW, Jarjour NN. The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am J Respir Crit Care Med 1997;156:1421-8.
18. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989;142:2393-400.
19. Levitzky MG. Pulmonary physiology. 5th ed. New York: McGraw-Hill; 1999.
20. Gibson PG, Girgis-Gabardo A, Morris MM. Mattoli S, Kay JM, Dolovich J, et al. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 1989;44:693-9.
21. Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J Allergy Clin Immunol 1999;103:232-7.
22. de Kluijver J, Evertse CE, Schrumpf JA, Van V, Zwinderman AH, Hiemstra PS, et al. Asymptomatic worsening of airway inflammation during low-dose allergen exposure in asthma: protection by inhaled steroids. Am J Respir Crit Care Med 2002;166:294-300.
23. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-9.
24. Ronchi MC, Piragino C, Rosi E, Amendola M, Duranti R, Scano G. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 1996;51:1000-4.
25. Virchow JC Jr. Holscher U, Virchow C Sr. Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis 1992;146:604-6.
26. Sedgwick JB, Calhoun WJ, Gleich GJ, Kita H, Abrams JS, Schwartz LB, et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991;144:1274-81.
27. Meerschaert J, Vrtis RF, Shikama Y, Sedgwick JB, Busse WW, Mosher DF. Engagement of α4β7 integrins by monoclonal antibodies or ligands enhances survival of human eosinophils in vitro. J Immunol 1999;163:6217-27.
28. Esnault S, Malter JS. Granulocyte macrophage-colony-stimulating factor mRNA is stabilized in airway eosinophils and peripheral blood eosinophils activated by TNF-α plus fibronectin. J Immunol 2001;166:4658-63.
29. Mattoli S, Mattoso VL. Soloperto M, Allegra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol 1991;87:764-802.
30. Meerschaert JA, Kelly EA, Mosher DF. Busse WW, Jarjour NN. Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1999;159:619-25.
31. Kuo HP, Wang CH, Lin HC, Hwang KS, Liu SL, Chung KF. Interleukin-5 in growth and differentiation of blood eosinophil progenitors in asthma: effect of glucocorticoids. Br J Pharmacol 2001;134:1539-47.
32. Palmqvist M, Cui ZH, Sjostrand M, Linden A, Lotvall J. Reduced late asthmatic response by repeated low-dose allergen exposure. Eur Respir J 2001;17:872-80.